Role of Probiotics in the Management of Helicobacter pylori Original paper

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

September 12, 2025

  • Microbes
    Microbes

    Microbes, short for microorganisms, are tiny living organisms that are ubiquitous in the environment, including on and inside the human body. They play a crucial role in human health and disease, functioning within complex ecosystems in various parts of the body, such as the skin, mouth, gut, and respiratory tract. The human microbiome, which is […]

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

Last Updated: 2025-09-12

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Divine Aleru

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

What was studied?

This review investigates the role of probiotics in the management of Helicobacter pylori (H. pylori) infection, a major cause of gastric disorders such as gastritis, peptic ulcers, and gastric cancer. The study examines how probiotics may be used as adjunctive therapy alongside traditional antibiotics to eradicate H. pylori more effectively, while minimizing the adverse effects commonly associated with antibiotic treatments, such as diarrhea and gastric disturbances. The review discusses the mechanisms by which probiotics, particularly strains of Lactobacillus and Bifidobacterium, compete with H. pylori for adhesion sites in the gut, produce antimicrobial substances like lactic acid and hydrogen peroxide, and modulate the immune response to enhance treatment efficacy.

Who was studied?

The review includes clinical trials, meta-analyses, and randomized controlled studies involving individuals infected with H. pylori, as well as studies focusing on the use of probiotics as part of treatment regimens. Probiotic strains such as Lactobacillus reuteri, Lactobacillus acidophilus, Bifidobacterium, and Saccharomyces boulardii were studied for their efficacy in reducing H. pylori colonization, enhancing gastric mucosal protection, and alleviating side effects of conventional therapy. The review draws on studies from diverse populations, including those from Asia and Europe, to examine how probiotics influence gastric microbiota composition and contribute to the improvement of gastric symptoms and treatment compliance. Studies also focused on patients with gastrointestinal disorders and those undergoing standard H. pylori eradication therapy (including triple or quadruple antibiotic regimens) combined with probiotic supplementation.

Most important findings

The review identifies several key findings related to the role of probiotics in managing H. pylori infection. First, it highlights the mechanisms of action of probiotics, noting that they compete with H. pylori for intestinal adhesion sites, thereby preventing bacterial colonization and reducing infection load. Additionally, probiotics were found to enhance the immune system, increasing the production of IgA antibodies and promoting mucosal barrier integrity, both of which contribute to protecting the stomach lining from H. pylori-induced damage. The study also emphasized the reduction of side effects such as diarrhea, which often occur during antibiotic therapy, and increased eradication rates when probiotics are used alongside standard treatments. Several clinical trials showed that combining probiotics with antibiotic regimens increased H. pylori eradication rates by 6-15% compared to antibiotic therapy alone, suggesting that probiotics offer significant clinical benefits. However, the review also notes that the effectiveness of probiotics can vary depending on the strain used and the dosage, with some probiotics showing more promise than others in eradicating H. pylori or reducing its pathogenicity.

Key implications

The findings suggest that probiotics can play a vital role in improving H. pylori treatment outcomes by increasing eradication rates and reducing side effects associated with antibiotic use. Given the rise in antibiotic resistance and the growing need for alternative therapies, the study highlights the potential of probiotics as a cost-effective and safer adjunct to conventional treatment regimens. Probiotic supplementation can help restore gastric microbial balance, support mucosal healing, and reduce gastric inflammation, thus improving patient compliance with treatment. The findings also underline the importance of selecting the right probiotic strain for H. pylori management, as not all probiotics are equally effective. Future clinical trials are needed to determine the optimal probiotic strains, doses, and treatment durations to maximize therapeutic benefits.

Probiotics

Probiotics are live microorganisms that offer significant health benefits when administered in adequate amounts. They primarily work by modulating the gut microbiome, supporting a balanced microbial ecosystem. Probiotics have been shown to improve gut health, modulate immune responses, and even influence metabolic and mental health disorders. With growing evidence supporting their therapeutic potential, probiotics are increasingly recognized for their role in treating conditions like irritable bowel syndrome (IBS), antibiotic-associated diarrhea (AAD), and even mental health conditions like depression and anxiety through their impact on the gut-brain axis.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.